Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ALKS compared with KYMR: revenue, margins and what each company keeps, and the suppliers and customers both name
ALKS
Alkermes plc.
Change
Mkt cap
Revenue
Revenue
KYMR
Kymera Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ALKS
Alkermes plc.
vs
KYMR
Kymera Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
ALKS
Alkermes plc.
Change
45.33
▼
−0.09%
· post 45.33
Mkt cap
$7.6B
Revenue
$496M
Q2 FY26
Revenue
$1.5B
FY25
KYMR
Kymera Therapeutics, Inc.
Change
126.75
▲
+3.38%
· post 128.47
Closed
Oct 30 '26
Mkt cap
$10.8B
Revenue
$65M
Q2 FY26
Revenue
$39M
FY25
vs
Compare
Closed
Oct 30 '26
ALKS
Alkermes plc.
vs
KYMR
Kymera Therapeutics, Inc.
45.33
▼
−0.09%
post 45.33
Price
126.75
▲
+3.38%
post 128.47
$7.6B
Mkt cap
$10.8B
Q2 FY26
$496M
Revenue
$65M
Q2 FY26
FY25
$1.5B
Revenue
$39M
FY25
Change
Change
ALKS
45.33
▼
−0.09%
vs
KYMR
126.75
▲
+3.38%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ALKS, solid
KYMR, dashed
Supply-chain overlap
Revenue flow
ALKS: latest quarter not drawable. KYMR: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ALKS
4
BIIB
Biogen
customer
VEEV
Veeva Systems
supplier
TEVA
Teva
customer
—
Amneal
unlisted
customer
Shared
0
No shared counterparties.
Only KYMR
4
GILD
Gilead Sciences
customer
VERX
Vertex Pharmaceuticals
customer
SNY
Sanofi
customer
SNYNF
Sanofi
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR